Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))

Hoi Wing Leung, Eunice Yuen Ting Lau, Carmen Oi Ning Leung, Martina Mang Leng Lei, Etienne Ho Kit Mok, Victor Wan San Ma, William Chi Shing Cho, Irene Oi Lin Ng, Jing Ping Yun, Shao Hang Cai, Hua Jian Yu, Stephanie Ma, Terence Kin Wah Lee (Corresponding Author)

Research output: Journal article publicationComment/debate/erratum

Abstract

The authors regret that incorrect grant number was provided in the Acknowledgements section. The last sentence of the Acknowledgements should read “This study was supported by the RGC General Research Fund (17120215)”. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)2
Number of pages1
JournalCancer Letters
Volume499
DOIs
Publication statusPublished - 28 Feb 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum to “NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma” [Canc. Lett. 476 (2020) 48–56] (Cancer Letters (2020) 476 (48–56), (S0304383520300707), (10.1016/j.canlet.2020.02.008))'. Together they form a unique fingerprint.

Cite this